Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells-Reference-Cited by-同舟云学术

Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2V617F driven cells

Published:2022-09 Issue: Volume:83 Page:105384
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Fernandes Jaqueline Cristina,Fenerich Bruna Alves,Alves-Silva Antônio Bruno,Fonseca Natasha Peixoto,Coelho-Silva Juan Luiz,Scheucher Priscila Santos,Rego Eduardo Magalhães,Figueiredo-Pontes Lorena Lôbo,Machado-Neto João Agostinho,Traina Fabiola

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference28 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

2. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody;Chapuis;Haematologica,2010

3. How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?;Chen;Hematology Am Soc Hematol Educ Program,2014

4. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms;de Melo Campos;Oncotarget,2016

5. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study;Fassnacht;Lancet Oncol.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NT157 as an Anticancer Drug Candidate That Targets Kinase- and Phosphatase-Mediated Signaling;Kinases and Phosphatases;2024-05-29

2. NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma;Hematology, Transfusion and Cell Therapy;2024-03